Felicita Andreotti

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 23

Top Topics

Atrial Fibrillation

Cardiovascular Events

Top Venues

European heart journal

Journal of clinical medicine

Journal of applied physiology (Bethesda, Md. : 1985)

This page only lists publications with an associated author ORCID identifier.

Publications

Felicita Andreotti, Raffaele De Caterina
Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed. European heart journal 45 (29) (2024)
Felicita Andreotti, Michelle L O'Donoghue, Jurriën M Ten Berg
The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment. European heart journal (2024)
Felicita Andreotti, Francesco Burzotta, Aldo Pietro Maggioni
Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance". Circulation 149 (24) (2024)
Iris Parrini, Giovanni De Luca, Carmelo Massimiliano Rao, Stefano Cacciatore, Carmine Riccio, Massimo Grimaldi, Michele Massimo Gulizia, Fabrizio Oliva, Felicita Andreotti
How to Manage Beta-Blockade in Older Heart Failure Patients: A Scoping Review. Journal of clinical medicine 13 (7) (2024)
Felicita Andreotti, Raffaele De Caterina
Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed. European heart journal 45 (29) (2024)
Iris Parrini, Giovanni De Luca, Carmelo Massimiliano Rao, Stefano Cacciatore, Carmine Riccio, Massimo Grimaldi, Michele Massimo Gulizia, Fabrizio Oliva, Felicita Andreotti
How to Manage Beta-Blockade in Older Heart Failure Patients: A Scoping Review. Journal of clinical medicine 13 (7) (2024)
Christiaan J M Vrints, Felicita Andreotti, Konstantinos C Koskinas, Xavier Rossello, Marianna Adamo, James Ainslie, Adrian Paul Banning, Andrzej Budaj, Ronny Ralf Buechel, Giovanni Alfonso Chiariello, Alaide Chieffo, Ruxandra Maria Christodorescu, Christi Deaton, Torsten Doenst, Hywel W Jones, Vijay Kunadian, Julinda Mehilli, Milan Milojevic, Jan J Piek, Francesca Pugliese, Andrea Rubboli, Anne Grete Semb, Roxy Senior, Jurrien M Ten Berg, Eric Van Belle, Emeline Van Craenenbroeck, Rafael Vidal-Perez, Simon Winther, null null
2024 ESC Guidelines for the management of chronic coronary syndromes. European heart journal (2024)
Iris Parrini, Giovanni De Luca, Carmelo Massimiliano Rao, Stefano Cacciatore, Carmine Riccio, Massimo Grimaldi, Michele Massimo Gulizia, Fabrizio Oliva, Felicita Andreotti
How to Manage Beta-Blockade in Older Heart Failure Patients: A Scoping Review. Journal of clinical medicine 13 (7) (2024)
Felicita Andreotti, Raffaele De Caterina
Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed. European heart journal (2024)
Felicita Andreotti, Michelle L O'Donoghue, Jurriën M Ten Berg
The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment. European heart journal 45 (19) (2024)
Felicita Andreotti, Tobias Geisler, Jean Philippe Collet, Bruna Gigante, Diana A Gorog, Sigrun Halvorsen, Gregory Y H Lip, Joao Morais, Eliano Pio Navarese, Carlo Patrono, Bianca Rocca, Andrea Rubboli, Dirk Sibbing, Robert F Storey, Freek W A Verheugt, Gemma Vilahur
Acute, periprocedural and longterm antithrombotic therapy in older adults. European heart journal (2022)
Adelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, Valentina Iervolino, Giuseppe Biondi Zoccai, Felicita Andreotti
Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies. Pharmaceutics 15 (1) (2022)
Adelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, Valentina Iervolino, Giuseppe Biondi Zoccai, Felicita Andreotti
Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies. Pharmaceutics 15 (1) (2022)
Adelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, Valentina Iervolino, Giuseppe Biondi Zoccai, Felicita Andreotti
Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies. Pharmaceutics 15 (1) (2022)
Silvia Calabria, Felicita Andreotti, Giulia Ronconi, Letizia Dondi, Alice Campeggi, Carlo Piccinni, Antonella Pedrini, Immacolata Esposito, Alice Addesi, Nello Martini, Aldo Pietro Maggioni
Antiplatelet Therapy during the First Year after Acute Coronary Syndrome in a Contemporary Italian Community of over 5 Million Subjects. Journal of clinical medicine 11 (16) (2022)
Adelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, Valentina Iervolino, Giuseppe Biondi Zoccai, Felicita Andreotti
Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies. Pharmaceutics 15 (1) (2022)
Felicita Andreotti, Massimo Massetti, Jurrien M Ten Berg
Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS. European heart journal 43 (29) (2022)
Eliano Pio Navarese, Felicita Andreotti
Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes. European heart journal 42 (45) (2021)
Aldo Pietro Maggioni, Felicita Andreotti
Closing the Gap Between Populations Enrolled in Traditional Randomized Controlled Trials and Patients Encountered in Clinical Practice: The Case of Heart Failure. Circulation. Heart failure 14 (9) (2021)
Diana Adrienne Gorog, Eliano P Navarese, Felicita Andreotti
Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention? European heart journal 42 (33) (2021)
Luis Ortega-Paz, Mattia Galli, Davide Capodanno, Francesco Franchi, Fabiana Rollini, Behnood Bikdeli, Roxana Mehran, Gilles Montalescot, C Michael Gibson, Renato D Lopes, Felicita Andreotti, Dominick J Angiolillo
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. European heart journal. Cardiovascular pharmacotherapy (2021)
Felicita Andreotti, Giulio Coluzzi, Teodosio Pafundi, Teresa Rio, Eliano Pio Navarese, Filippo Crea, Massimo Pistolesi, Attilio Maseri, Charles H Hennekens
Last Word on Viewpoint: Anemia contributes to cardiovascular disease through reductions in nitric oxide. Journal of applied physiology (Bethesda, Md. : 1985) 122 (2) (2018)
Felicita Andreotti, Giulio Coluzzi, Teodosio Pafundi, Teresa Rio, Eliano Pio Navarese, Filippo Crea, Massimo Pistolesi, Attilio Maseri, Charles H Hennekens
Anemia contributes to cardiovascular disease through reductions in nitric oxide. Journal of applied physiology (Bethesda, Md. : 1985) 122 (2) (2016)